RT Journal Article
SR Electronic
T1 Mechanisms controlling membrane recruitment and activation of autoinhibited SHIP1
JF bioRxiv
FD Cold Spring Harbor Laboratory
SP 2023.04.30.538895
DO 10.1101/2023.04.30.538895
A1 Grace L. Waddell
A1 Emma E. Drew
A1 Henry P. Rupp
A1 Scott D. Hansen
YR 2023
UL http://biorxiv.org/content/early/2023/05/01/2023.04.30.538895.abstract
AB Signal transduction downstream of growth factor and immune receptor activation relies on the production of phosphatidylinositol-(3,4,5)-trisphosphate (PI(3,4,5)P3) lipids by phosphoinositide-3-kinase (PI3K). Regulating the strength and duration of PI3K signaling in immune cells, Src homology 2 domain-containing inositol 5-phosphatase 1 (SHIP1) controls the dephosphorylation of PI(3,4,5)P3 to generate PI(3,4)P2. Although SHIP1 has been shown to regulate neutrophil chemotaxis, B-cell signaling, and cortical oscillations in mast cells, the role that lipid and protein interactions serve in controlling SHIP1 membrane recruitment and activity remains unclear. Using single molecule TIRF microscopy, we directly visualized membrane recruitment and activation of SHIP1 on supported lipid bilayers and the cellular plasma membrane. We find that SHIP1’s interactions with lipids are insensitive to dynamic changes in PI(3,4,5)P3 both in vitro and in vivo. Very transient SHIP1 membrane interactions were detected only when membranes contained a combination of phosphatidylserine (PS) and PI(3,4,5)P3 lipids. Molecular dissection reveals that SHIP1 is autoinhibited with the N-terminal SH2 domain playing a critical role in suppressing phosphatase activity. Robust SHIP1 membrane localization and relief of autoinhibition can be achieved through interactions with immunoreceptor derived phosphopeptides presented either in solution or conjugated to supported membranes. Overall, this work provides new mechanistic details concerning the dynamic interplay between lipid binding specificity, protein-protein interactions, and activation of autoinhibited SHIP1.Competing Interest StatementThe authors have declared no competing interest.